Product

Liposomal bupivacaine

Aliases
Exparel, EXPAREL, liposomal bupivacaine

39 clinical trials

51 indications

Indication
Pain
Indication
Postoperative
Indication
Burns
Indication
Wrist Fractures
Indication
Breast Cancer
Indication
Lobectomy
Indication
Opioid Use
Indication
Toxicity
Indication
Medication
Indication
Amputation
Indication
Oropharyngeal
Indication
Liver Cancer
Indication
Severe Obesity
Indication
Osteoarthritis
Indication
Abdominoplasty
Indication
Cardiac surgery
Indication
Unspecified
Indication
Acute
Indication
Surgery
Indication
Analgesic
Indication
Herniated Disc
Indication
Anesthesia
Indication
Sciatica
Indication
Scleroderma
Indication
Diffuse
Indication
c-section
Clinical trial
Pecto-Intercostal Fascial Plane Block for Enhanced Recovery After Cardiac Surgery
Status: Completed, Estimated PCD: 2023-09-03
Clinical trial
Stopping Opioid Overuse in Obstetrics to Halt Exposure Trial
Status: , Estimated PCD: 2024-04-01
Clinical trial
Liposomal Bupivacaine vs Peripheral Nerve Block
Status: Terminated, Estimated PCD: 2021-06-30
Clinical trial
Chemical Sympathectomy Following Peripheral Nerve Block With Liposomal Bupivacaine
Status: Terminated, Estimated PCD: 2016-03-01